Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (12) , 1433-1442
- https://doi.org/10.1016/s0149-2918(00)83042-8
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Upper Gastrointestinal Tract Safety Profile of AlendronateArchives of internal medicine (1960), 2000
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, MinnesotaGastroenterology, 1997
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995